ACSL4 and neoplasm: Because phosphorylation of different sites on ACSL4 may confer distinct biological effects, with mass spectrometric analysis, we found that the T679 residue phosphorylation level of ACSL4 was markedly decreased in HONE1-derived TRCs compared to bulk tumor cells (Fig. 3b).